Targeting ovarian solid tumors by Elastin-like polypeptide drug conjugates: Current trends and future prospectives
CONCLUSION: Elastin-like polypeptides (ELP), one of the thermoresponsive polymers, have been identified as drug carriers in anticancer therapy. ELP-drug conjugates have the potential and can be used effectively in combination with hyperthermia for targeting drugs to solid tumors. This review reports on the use of ELPs in cancer therapy, its biomedical applications, and recent developments to target medicines to solid ovarian tumors.PMID:34259143 | DOI:10.2174/1389203722666210713161618
Source: Current Protein and Peptide Science - Category: Biochemistry Authors: Deepthi Ramamurthi Moola Joghee Nanjan Chandrasekar Shanthi Bhupathi Santhosh Sunil Kumar Patnaik Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Ovarian Cancer | Ovaries | Science